A better understanding of how L-carnitine interacts with other metabolic substrates and the existing pharmacological therapies currently available for use in patients could lead to optimal strategies for integrating L-carnitine with existing therapy
The active ingredient in Victoza, liraglutide, can cause weight loss
Moreover, the observed high incidence of MACEs, which reached 12.0% in the non-users during follow-up, highlights the elevated cardiovascular risk among KTRs with T2DM, underscoring the importance of incorporating GLP-1 RAs into the DM care for these specific population
For most, these episodes were mild to moderate and often occurred during the dose escalation phasethe period when the dosage is gradually increased every four weeks
If you have a persistent funny taste in your mouth, dont just try to mask the symptoms, Dr